Low-dose oral hydroxychloroquine led to impaired vision in a child with renal failure: Case report and literature review.
Medicine (Baltimore)
; 100(10): e24919, 2021 Mar 12.
Article
in English
| MEDLINE | ID: covidwho-1138017
ABSTRACT
INTRODUCTION:
Hydroxychloroquine (HCQ) has received much attention in the treatment of coronavirus disease 2019 recently. However, it can cause irreversible vision loss. Few cases have been reported in pediatric patient with HCQ-related adverse reactions. Appropriate administration and early disease recognition are important for reducing the adverse drug reactions of HCQ. PATIENT CONCERNS We report a case of a 14-year-old Chinese girl who sought treatment for rapidly decreasing vision in the left eye over 3 days. The simulation results of the population pharmacokinetic model of HCQ revealed that the plasma concentration of HCQ abnormally increased before the visual acuity of the eye decreased. DIAGNOSIS She was diagnosed as HCQ related drug adverse reaction.INTERVENTIONS:
The daily dose of HCQ for this patient was adjusted from 100âmg/d to 50âmg/d.OUTCOMES:
Follow-up for 6 months showed no more vision loss recurrence. However, the existing decreased visual acuity of the eye did not recover either.CONCLUSION:
Although decreased visual acuity is an infrequent symptom, ophthalmologists should be aware of the possibility of HCQ concentration enrichment and consider minimizing HCQ use when a child with renal hypofunction seeks treatment for shortsightedness.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vision, Low
/
Hydroxychloroquine
Type of study:
Case report
/
Cohort study
/
Prognostic study
/
Reviews
Limits:
Adolescent
/
Female
/
Humans
Language:
English
Journal:
Medicine (Baltimore)
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS